Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x100px

Person › Details

Ronald (Ron) Scott (Basilea Pharmaceutica Ltd. (SIX: BSLN))

Scott, Ronald (Ron) (Basilea 201212–201804 CEO before COO before CFO RETIRED 2/18 proposed for Board)

	Organisation	Basilea Pharmaceutica Ltd. (SIX: BSLN)
	Product	Toctino®
	Product 2	antibiotic

Record changed: 2019-06-09

Picture Berlin Partner Voices Robinson Data for Precision Medicine 650x200px

More documents for Ronald (Ron) Scott

[1] Basilea Pharmaceutica Ltd.. (12/1/17). "Press Release: Basilea Extends Existing License Agreement with Pfizer for Antifungal Cresemba (isavuconazole) to China and Asia Pacific". Basel....
[2] Basilea Pharmaceutica Ltd.. (6/14/17). "Press Release: Basilea Announces License Agreement with Pfizer for Antifungal Cresemba (isavuconazole) for Europe, Russia, Turkey and Israel". Basel....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)